A Recap of Ax-S Thursdays Session #1
On Thursday, February 11, 2021, a panel of Healthcare leaders answered an important question: How well have we utilized existing pathways to make new COVID-19 medicines available in healthcare prior to their full marketing approval? Different countries have their own versions of the “Emergency Use Authorization”, but there are also “Expanded Access Programs” which are […]
What Happened to Expanded Access to New Medicines?
It is the true hybrid of clinical research and clinical care. A way of providing treatment-use or preventative-use access to groups of people in the target population who cannot participate in clinical trials, Expanded Access is important for doctors and patients who have the greatest unmet needs. Expanded Access Programs (EAPs) can also generate valuable […]